Depomed may take lagal route to protect the patent rights of it extended release antidiabetic pill Glumetza even as Lupin seeks regulatory approval to market a generic version of the the drug in US.

Swedish drug maker AstraZeneca has filed a lawsuit against India's generic firm Lupin for allegedly violating its valid patents on its gastric reflux disease drug Nexium (esomeprazole magnesium delayed release capsules) though seeking to sell a generic version in US.

At least 3 of Glenmark lead molecules failed or got suspended in mid-stage trials in the recent months

Indian generic firm Wockhardt has denied press reports of a possible sell-out of its biotech business to the world’s largest drug maker Pfizer.

OxyContin was the ninth most-selling drug in the US in 2008 with sales of $2.5 billion

Sun Pharma had settled a similar patent dispute with Forest on Lexapro in July

DCGI's directive to issue CoPP only through CDSCO has already been stayed by 2 high court orders

Reports of DCGI's criminal proceedings is a malicious campaign by rival firm, alleges Natco

Indian pharma exporters secure the highest number - 31% - of manufacturing quality certificates (CEPs) granted by EDQM during January – July 2009

A regional Indian High Court has issued an injunction staying an order that aimed to restrict issuance of product manufacturing licences by state drug agencies, throwing a spanner on the central drug authority's efforts to streamline the licensing practices to ensure quality of drug products manufactured across the country.